Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Hemopatch as a Sealant at the Pancreaticojejunostomy After Pancreatoduodenectomy to Prevent Postoperative Pancreatic Fistula

NCT03419676 is registered in ClinicalTrials.gov with Hospital Miguel Servet as lead sponsor.

NCT NCT03419676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03419676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Hemopatch as a Sealant at the Pancreaticojejunostomy After Pancreatoduodenectomy to Prevent Postoperative Pancreatic Fistula
Lead sponsor
Hospital Miguel Servet
Phase
Phase 3
Overall status
Completed
Start date
May 1, 2018
Completion date
February 10, 2022
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic fistula